MOTS-c

Overview

What is MOTS-c?

MOTS-c is a 16 amino acid peptide encoded within the mitochondrial genome, identified around 2015 and studied as an exercise mimetic. Research centres on AMPK activation, insulin sensitivity and metabolic regulation, with no clinical efficacy trials in people.

• Metabolic Health
• Mitochondrial Function
• Exercise Support
• Longevity

What the research reports

Reported benefits of MOTS-c

Outcomes described across the published MOTS-c literature and ongoing study. Read each as research context rather than a promised personal result.

1. 01

   AMPK pathway activation work

   Preclinical work describes activation of AMPK, one of the same energy sensing pathways that physical exercise switches on in muscle. Reported in research settings.

2. 02

   Exercise mimetic research

   Studied under the exercise mimetic label because of that shared pathway, though no trial has shown it reproduces training outcomes. Reported in research settings.

3. 03

   Insulin sensitivity studies

   Animal studies report improved glucose handling and insulin sensitivity, mostly in mouse models of diet induced metabolic disease. Reported in research settings.

4. 04

   Mitochondrial signalling role

   As a mitochondrial derived peptide it is studied as a signal between mitochondria and the cell nucleus during metabolic stress. Reported in research settings.

5. 05

   Longevity research interest

   Interest stems from age related decline in circulating levels, an observational finding rather than a demonstrated intervention effect. Reported in research settings.

Dosage and protocol

How MOTS-c is typically studied

Research protocols report 5 to 10 mg two or three times weekly across 4 to 8 weeks of a cycle. These figures reflect vendor and clinic convention rather than any published clinical trial.

Route

Subcutaneous injection

Example range

5-10 mg

Frequency

Two to three times weekly

Timing

Morning dosing is common. Some protocols place it before exercise.

Clinical evidence

MOTS-c clinical evidence summary

The published MOTS-c record, labeled by strength so you can see what is settled and what is still emerging.

Interactions

How MOTS-c pairs with other peptides

NAD+ coenzyme

Synergistic for mitochondrial function. Both act on cellular energy pathways by complementary routes.

SS-31 peptide

Both target mitochondria by separate routes, one through signalling and one through cardiolipin binding.

Metformin use

Both influence AMPK signalling, so overlap is plausible although no study has examined the pairing.

5-Amino-1MQ

Both are marketed for metabolic outcomes, but no research has examined them used together.